1. Burst-Like Subcutaneous Electrical Stimulation Induces BDNF-Mediated, Cyclotraxin B-Sensitive Central Sensitization in Rat Spinal Cord
- Author
-
Jeffri Retamal, Andrea Reyes, Paulina Ramirez, David Bravo, Alejandro Hernandez, Teresa Pelissier, Luis Villanueva, Luis Constandil, Institut de psychiatrie et neurosciences de Paris (IPNP - U1266 Inserm - Paris Descartes), and Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
0301 basic medicine ,medicine.medical_specialty ,[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology ,Stimulation ,Tropomyosin receptor kinase B ,cyclotraxin-B ,windup ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Cyclotraxin-B ,Pharmacology (medical) ,ComputingMilieux_MISCELLANEOUS ,Sensitization ,Original Research ,hyperalgesia ,C-reflex ,Pharmacology ,Brain-derived neurotrophic factor ,subcutaneous electrical stimulation ,business.industry ,lcsh:RM1-950 ,brain-derived neurotrophic factor ,Long-term potentiation ,Spinal cord ,lcsh:Therapeutics. Pharmacology ,030104 developmental biology ,Endocrinology ,medicine.anatomical_structure ,nervous system ,Hyperalgesia ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Intrathecal administration of brain derived neurotrophic factor (BDNF) induces long-term potentiation (LTP) and generates long-lasting central sensitization in spinal cord thus mimicking chronic pain, but the relevance of these observations to chronic pain mechanisms is uncertain. Since C-fiber activation by a high-frequency subcutaneous electrical stimulation (SES) protocol causes spinal release of BDNF and induces spinal cord LTP, we propose that application of such protocol would be a sufficient condition for generating long-lasting BDNF-mediated central sensitization. Results showed that application of burst-like SES to rat toes produced (i) rapid induction of hyperalgesia that lasted for more than 3 weeks, (ii) early increase of C-reflex activity followed by increased wind-up scores lasting for more than 1 week, and (iii) early increase followed by late decrease in BDNF protein levels and phosphorylated TrkB that lasted for more than 1 week. These changes were prevented by the TrkB antagonist cyclotraxin-B administered shortly before SES, while hyperalgesia was reversed by cyclotraxin-B administered 3 days after SES. Results suggest that mechanisms underlying central sensitization first involve BDNF release of probably neuronal origin, followed by brief increased expression of likely glial BDNF and pTrkB that could switch early phase sensitization into late one.
- Published
- 2018